Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. Norway
  4. Oslo Bors
  5. Aker BioMarine AS
  6. News
  7. Summary
    AKBM   NO0010886625


SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Aker BioMarine : Organizational change and ramp-up of Kori Krill Oil distribution in the US

09/17/2021 | 02:00am EDT
Aker BioMarine appoints industry leader Seth French as new CEO for the company's
Brands segment. Mr. French will report to CEO in Aker BioMarine, Matts Johansen.

"With his broad experience from the food and beverage industry, his strategic
mindset and solid track record, Seth will be an excellent addition to the team.
He will play an important part by leading the expansion of Brands in the US
market", says Mr. Johansen.    

Most recently, Mr. French was president in Lassonde Pappas Private Label
Division, one of the premier private brand beverage companies in the US. He has
held various top positions in Lassonde Pappas for the last 14 years. 
"Aker BioMarine is a very exciting company that has proven itself to be an
innovative player in the healthy supplements and nutrition market and a leading
force in terms of market development. I am excited by the growth opportunities
ahead" says Mr. French.

As a part of building the brand segment, Aker BioMarine bought Lang Pharma
Nutrition in 2019. Lang is a key partner to the world's leading mass market
retail chains such as Costco, Sam's Club, Walmart, Target, CVS and Walgreens,
and is supplying dietary supplement and nutrition products. The U.S. vitamin and
supplement industry is a growing market, and for Aker BioMarine it is especially
important to develop and expand the omega-3 category.

In 2020, Aker BioMarine established Epion, a consumer brand company delivering
Kori Krill Oil in the US market. Today, the brand is available in retail chains
in the US, including Costco, CVS, Sam's Club, Target, Wakefern, Walgreens,
Walmart and more. One of these retail chains has awarded Epion a significant
increase in distribution of Kori from the first quarter of 2022. The impact of
the increased distribution is uncertain, but it is nevertheless an important
step towards our ambition for the Kori brand.

About Aker BioMarine 
AkerBioMarine is a biotech innovator and Antarctic krill-harvesting company,
dedicated to improving human and planetary health. Listed on Oslo Stock
Exchange, the company develops krill-based ingredients for pharmaceutical,
nutraceutical (Superba®), aquaculture (QRILL®Aqua), and animal feed applications
(QRILL®Pet), including INVITM, a highly concentrated protein isolate, and
LYSOVETATM, a targeted transporter of EPA and DHA from krill. Aker BioMarine's
fully transparent value chain stretches from sustainable krill harvesting in
pristine Antarctic waters through its Montevideo logistics hub, Houston
production plant, and to customers around the world. The company's strong focus
on sustainability inspired the launch of AION by Aker BioMarine, a circularity
company dedicated to helping companies to recycle and reuse waste. For further
information go to www.akerbiomarine.com

Click here for more information

© Oslo Bors ASA, source Oslo Stock Exchange

Stocks mentioned in the article
ChangeLast1st jan.
AKER BIOMARINE AS 0.34% 44.85 Real-time Quote.-61.91%
COSTCO WHOLESALE CORPORATION 1.68% 490.1 Delayed Quote.30.08%
All news about AKER BIOMARINE AS
01:04aAKER BIOMARINE : Krill Oil Patent Wins Validation In Europe
10/25AKER BIOMARINE : key patent for krill oil in Europe is validated
10/22AKER BIOMARINE ASA : - Invitation to presentation of the Q3 2021 results
10/18AKER BIOMARINE : appoints Thong Luu as SVP and GM to lead Asia
09/20AKER BIOMARINE : Mandatory notification of trade by primary insider
09/17AKER BIOMARINE : Organizational change and ramp-up of Kori Krill Oil distribution in the U..
09/17Aker BioMarine AS Appoints Seth French as New CEO for the Company’s Brands Segment
09/09AKER BIOMARINE : Company update and revised 2021 outlook
09/08Aker Biomarine AS Provides Operating Guidance for the Full Year 2021
09/08Aker Biomarine AS Revises Earnings Guidance for the Full Year 2021
More news
Sales 2021 2 318 M 278 M 278 M
Net income 2021 -281 M -33,6 M -33,6 M
Net Debt 2021 2 404 M 288 M 288 M
P/E ratio 2021 -14,1x
Yield 2021 -
Capitalization 3 919 M 470 M 469 M
EV / Sales 2021 2,73x
EV / Sales 2022 2,34x
Nbr of Employees 551
Free-Float 20,8%
Duration : Period :
Aker BioMarine AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AKER BIOMARINE AS
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus HOLD
Number of Analysts 3
Last Close Price 5,36 $
Average target price 6,08 $
Spread / Average Target 13,4%
EPS Revisions
Managers and Directors
Matts Eirik Johansen Chief Executive Officer
Katrine Mourud Klaveness Chief Financial Officer
Ola Sn°ve Chairman
Sindre Skjong Director & Technical Director
Trond Atle Smedsrud Executive Vice President-Strategic Investments
Sector and Competitors
1st jan.Capi. (M$)
KWS SAAT SE & CO. KGAA12.00%2 864
BAYWA AG28.18%1 474
THE ANDERSONS, INC.32.60%1 063